AU2001260270A1 - Liposomes containing active substances - Google Patents

Liposomes containing active substances

Info

Publication number
AU2001260270A1
AU2001260270A1 AU2001260270A AU6027001A AU2001260270A1 AU 2001260270 A1 AU2001260270 A1 AU 2001260270A1 AU 2001260270 A AU2001260270 A AU 2001260270A AU 6027001 A AU6027001 A AU 6027001A AU 2001260270 A1 AU2001260270 A1 AU 2001260270A1
Authority
AU
Australia
Prior art keywords
active substances
containing active
liposomes containing
liposomes
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260270A
Inventor
Gerd Berger
Jurgen Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEPT GmbH
Original Assignee
PHARMACEPT GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEPT GmbH filed Critical PHARMACEPT GmbH
Publication of AU2001260270A1 publication Critical patent/AU2001260270A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001260270A 2000-05-02 2001-05-02 Liposomes containing active substances Abandoned AU2001260270A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10021030.9 2000-05-02
DE10021030 2000-05-02
PCT/EP2001/004900 WO2001082892A2 (en) 2000-05-02 2001-05-02 Liposomes containing active substances

Publications (1)

Publication Number Publication Date
AU2001260270A1 true AU2001260270A1 (en) 2001-11-12

Family

ID=7640324

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260270A Abandoned AU2001260270A1 (en) 2000-05-02 2001-05-02 Liposomes containing active substances

Country Status (4)

Country Link
US (1) US20030124180A1 (en)
EP (1) EP1427393A2 (en)
AU (1) AU2001260270A1 (en)
WO (1) WO2001082892A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087105A1 (en) * 2003-04-02 2004-10-14 Celator Pharmaceuticals, Inc. Combination formulations of platinum agents and fluoropyrimidines
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
MX2007004955A (en) * 2004-11-08 2007-06-14 Transave Inc Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally.
EP1745788A1 (en) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acyglycerophospholipids for treating cancer and cachexia
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
DE102009031274A1 (en) 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomes for pulmonary application
US20110070291A1 (en) * 2009-09-11 2011-03-24 T*Amine, Llc. Food or beverage composition fortified with thyronamines and/or thyronamine precursors
JP2015530387A (en) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー Prevention of recurrence of lung cancer by lipid complexed cisplatin
US10639278B2 (en) * 2013-10-22 2020-05-05 Lipella Pharmaceuticals, Inc. Delivery of agents using metastable liposomes
WO2017097196A1 (en) * 2015-12-08 2017-06-15 正大天晴药业集团股份有限公司 Method for preparing liposome
DE102018006443A1 (en) * 2018-08-14 2020-02-20 Abnoba Gmbh Process for encapsulating active substances in liposomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176414A (en) * 1984-09-21 1986-04-18 Shionogi & Co Ltd Production of liposome preparation
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
DE69107844T2 (en) * 1990-04-18 1995-08-10 Takeda Chemical Industries, Ltd., Osaka LIPOSOME COMPOSITION.
CA2126648C (en) * 1993-11-09 2000-10-10 Tomas De Paoli Liposomes containing bioavailable iron (ii) and method for obtaining them
IL113139A0 (en) * 1994-03-28 1995-06-29 Nycomed Imaging As Diagnostic compositions comprising imaging agents encapsulated in liposomes
US5702722A (en) * 1994-09-30 1997-12-30 Bracco Research S.A. Liposomes with enhanced entrapment capacity, method and use
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
DE19724796A1 (en) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Antitumor therapy agents

Also Published As

Publication number Publication date
EP1427393A2 (en) 2004-06-16
WO2001082892A2 (en) 2001-11-08
US20030124180A1 (en) 2003-07-03
WO2001082892A3 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2002218250A1 (en) Medicament dispenser
AU6319698A (en) Liposomes containing active agents
AU2691801A (en) Secure receptacle
AU2164101A (en) Fungicidal combinations of active substances
AU2001289896A1 (en) Mechanically stable dosage forms containing ubiquinones
AU2001295657A1 (en) Formulation containing wax-esters
AU2001276627A1 (en) Drug containing polymeric micelles
AU2002223562A1 (en) Medicament dispenser
AU2001263839A1 (en) Liquid formulations
AU2001282607A1 (en) Solution preparations stabilized over long time
AU2001248833A1 (en) Stable liquid preparation
AU2001260270A1 (en) Liposomes containing active substances
AUPQ761100A0 (en) Lipophilic medicament
AU2001252603A1 (en) Liposomes containing hydrophobic iodo compound
AU2001232244A1 (en) Drug comprising combination
AU2001258792A1 (en) Insecticides
AU2001282527A1 (en) Antiparkinsonism drugs
AU2002218159A1 (en) Transparent active substance capsules
AU2001272718A1 (en) Medicaments
AU2002215902A1 (en) Medicament dispenser
AU2001292578A1 (en) Pharmaceutical compounds
AU2001260047A1 (en) Nozzle for disseminating active substances
AU2001266336A1 (en) Body-buried electrode
AU769925C (en) Improved container
AU2002223437A1 (en) Medicament dispenser